protectionthroughprevention™

You do everything you can to heal your patients. So why take chances with your infection prevention protocol? Clorox Healthcare® offers a comprehensive portfolio of surface disinfectants and breakthrough UV technology — backed by a century of expertise. Your needs are always evolving, so we’re continually innovating to create effective, ready-to-use, compliance-driven

sucof uoy stel stnemnorivne tneitap gnidraugefas ni rentrap ruoy gnieB .snoituloson what’s most important — providing the best possible care. For Sam.

Learn more at CloroxHealthcare.ca

Safeguarding patient environments requires advanced and evolving solutions.

When it comes to protecting Sam,is good enough good enough?

Use products as directed. © 2017 Clorox Professional Products Company. NI-36453

You do everything you can to heal your patients. So why take chances with your infection prevention offers a comprehensive portfolio of surface disinfectants and

breakthrough UV technology — backed by a century of expertise. Your needs are always evolving, so we’re continually innovating to create effective, ready-to-use, compliance-driven

Safeguarding patient environments requires advanced and evolving solutions.

Use products as directed. © 2017 Clorox Professional Products Company. NI-36453

Executive Briefing

Sponsored by:

Challenged by Surface Compatibility? Don’t Compromise: Disinfectant Innovations Eliminate the Need for TradeoffsBy Danielle Augustin-Glenn, PhD, Research Scientist, Clorox Healthcare

In healthcare facilities, nearly any surface in the environ-ment is susceptible to contamination with healthcare-asso-ciated infections (HAIs). Despite proactive infection control

measures, many of these pathogens can still survive on surfac-es long enough to be transmitted to patients and healthcare workers.1 The challenge the healthcare community faces is the spread of these pathogens through various means – from mat-tresses and bed rails to furniture and medical equipment. Ac-cording to a report by Office of Disease Prevention and Health Promotion, $33 billion in annual healthcare cost is attributed to preventable HAIs, 20 percent of which are associated with contamination related to medical devices.2 Understanding how and why these device and equipment-associated trans-missions occur and identifying appropriate solutions is a top priority for the healthcare community today.3

Proper cleaning and disinfection, with the appropriate dis-infectants, is a vital component of infection prevention pro-grams. In addition to legacy dilutable disinfectants that leverage quaternary ammonium compounds, technological advances in disinfectant chemistry have enabled the devel-opment of pre-mixed, ready-to-use, shelf-stable solutions that harness the power of fast-acting oxidative chemistries like bleach and hydrogen peroxide. Over time, these products have evolved to better suit the needs of a changing healthcare environment and balance two key priorities for environmental hygiene: efficacy and compatibility.

Most immediate of the two priorities is efficacy. Improvements in hospital cleaning and disinfection have been associated with reductions in healthcare-associated infection rates and the risk of acquiring multidrug-resistant organisms in hospital rooms that previously housed colonized or infected patients.4

While the disinfection of healthcare surfaces and equipment is essential for reducing the risk of HAIs, appropriate consid-eration and care must be taken to protect them from dam-age. According to a ECRI Institute report on health technology hazards, “use of cleaning agents or cleaning practices that are incompatible with the materials used in a medical device’s construction, or that are otherwise inappropriate for the de-vice’s design, can cause the device to malfunction or to fail prematurely, possibly affecting patient care.”5 The proper care of healthcare surfaces also has important implications for cost, patient satisfaction and public perception.

In a space where options are plentiful, but not always created equal, and diverse stakeholders often have competing prior-ities for product selection and use, healthcare facilities need solutions that meet high standards for efficacy and aesthetics, so they can fight healthcare-associated pathogens without damaging surfaces and limit unsightly residue left behind.

The Two-Part Compatibility Challenge Surface compatibility has become something of a buzzword for manufacturers. Generally speaking, the term is used to ref-erence the degree to which disinfectants are suitable for use on specific surfaces and equipment. But what makes a prod-uct suitable for use? When reviewing surface compatibility in-formation, there are two important considerations: aesthetic issues, like residue, and corrosion. There is no silver bullet. All disinfectants can cause compatibility issues if used improp-erly, but understanding potential challenges and selecting products designed to minimize them can help facilities pro-tect against pathogens and surface damage.

In today’s shifting healthcare landscape, the role of patient ex-perience has gained new prominence. Patients have the pow-er to not only impact public perception of healthcare facilities via social media and rankings, but also to influence reimburse-ment levels by participating in surveys submitted through

“In today’s shifting healthcare landscape, the role of patient experience has gained

new prominence. ”

— Danielle Augustin-Glenn, PhD, Research Scientist, Clorox Healthcare

14118

157459

1CloroxNI-36453_PPD_HC_Stnrdzn

PortfolioPrintAd_Beckers_R1 01/25/2017 cl

61221 BROADWAY #287OAKLAND CA 94612

510-271-6569

NI-36453_PPD_HC_StndznPortfolioPrintAd_Beckers PROCESS SPOT COLORS SPECIAL

BRAND PUB PROJECT MGR. / EXT.Create Mechanical for Beckers Full Pg. Ad PPD Becker’s Michelle Ogata x7511

PRINT INFO SUBSTRATE DIMENSIONS APPLICATION/VERSIONOffset / (4/0) Paper 8.375" W x 10.875" H InDesign CC15

01/23/17 / i4Color NOTES Dielines do not print.

3 4 5 6 7 8 9 10 11 12 13 14 15 R100/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00

- - - - - - - - - - - - - DESIGN REFERENCE

- - - - - - - - - - - - - NI-36214

PMSXXXXCPMSXXXXY

PMSXXXXMPMSXXXXK

PMSXXXX VPMSXXXX D

creativeARTWORK & IMAGES Rights: Have Limited No CCS

USAGERIGHTS (File Name or Description) and Source

493216407_GTY_RF_BoyInHospital_26-07-16-1611_cmyk_i1.psd

47689_GroupShot_AB.psd

PPD_UVDevice_Version1_AB.psd

Clorox Healthcare logo

File Name or Description here and Source here

File Name or Description here and Source here

File Name or Description here and Source here

ARTWORK RETRIEVAL APPROVALP&T REVIEW Andrew G. DATE 01/05/17

Executive Briefing

HCAHPS. As a result, aesthetic issues noticed by patients, like residue — anything left behind on surfaces after the cleaning or disinfecting product dries — can become problematic. All commercially available cleaning and disinfecting products can leave residue on surfaces. Salt residue, which without rins-ing, may be left behind on surfaces treated with bleach-based disinfectants, is often the most visible. While healthcare pro-fessionals may recognize salt residue as a sign that surfaces have been disinfected with bleach and are less likely to harbor pathogens, to the layperson, visible residue may suggest the surface is dirty.

The other key compatibility challenge is corrosion, which re-fers to actual damage to surfaces and equipment. This is some-times a concern when using powerful sporicidal disinfectants, because the oxidizing action which makes them so effective against microorganisms can also impact surfaces. Damage caused by corrosion can lead to costly repairs or replace-ments and also has safety implications. Corrosion can cause pitting, or otherwise compromise the integrity of healthcare surfaces, increasing the risk of contamination and limiting the efficacy of treatment with manual surface disinfectants.

Trade-Offs Leave Facilities VulnerableWhile focused on reducing HAI rates, healthcare facilities also face significant pressure to minimize compatibility issues. From an administrative perspective, hospitals must safeguard financial investments in facility maintenance and expensive medical equipment. On the front lines, clinical staff and EVS workers are often the first blamed for complaints about corro-sion or residue. Torn between the disinfectants they need to use to quickly kill dangerous pathogens and products that are easier to use, facilities may make risky trade-offs to manage these pressures.

For example, hospitals might opt to trade down from a spori-cidal product with broad-spectrum microefficacy and short contact times to weaker disinfectants like quats, which many assume can do a “good enough” job to justify the trade-off for better aesthetics. In such a scenario, corrosion and residue might be limited, but at the expense of efficacy, potentially leaving patients vulnerable to dangerous bacteria like Clos-tridium difficile (C. difficile). Nearly 500,000 Americans suffer from C. difficile infections every year and almost 30,000 die as a result.6 Unlike a sporicidal disinfectant, quat products do not kill C. difficile spores.

Eliminating Trade-Offs: Finding the Right DisinfectantThere are a few key characteristics worth considering in select-ing the ideal disinfectant for your facility:

1. Efficacy: Your disinfectant should have a wide antimicro-bial spectrum, including kill claims for the pathogens that commonly cause HAIs and outbreaks. Long trusted for their broad-spectrum disinfection efficacy and utility in C. difficile prevention protocols, Clorox Healthcare® Bleach Germicidal Wipes are now EPA-registered to kill 58 microorganisms in three minutes or less.

2. Compatibility: Look for products with broad surface com-patibility or those that are specially formulated for compati-bility with surfaces commonly found in healthcare settings. Through the Clorox Healthcare Compatible™ program, Clo-rox Healthcare works with medical equipment manufacturers to evaluate and test compatibility across its portfolio of disin-fectants on common surfaces and equipment.

3. Contact time: Products with short contact times (e.g., 30 seconds to three minutes) help ensure faster room turnover and compliance. Wet-contact time is another critical compo-nent; if the product evaporates from the surface before the kill time is achieved, it may not be effective. The best disinfecting products have a wet-contact time greater than or equal to kill times listed on their label.

4. Ease of use and aesthetics: When products are easy to use, there is less chance for error. Products should be effective in the presence of organic matter, have an acceptable odour pro-file, be shelf-stable, soluble in water and have simple direc-tions for use. Ideal products should clean and disinfect in one step and be available in multiple forms with low-residue so no extra wiping step is required.

Other disinfectant selection factors include training and sup-port offered by the manufacturer, cost and standardization. The best suppliers can help you identify the right products to meet your facility’s unique needs and will offer onsite training and ongoing education to help support implementation.

No Compromising on CompatibilityClorox Healthcare offers the most robust portfolio of EPA-reg-istered surface cleaners and disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehen-sive approach to environmental hygiene for HAI prevention. Long trusted as a leader in disinfectant efficacy, Clorox Health-care also understands the challenges facilities face in balanc-ing the need to protect patients from dangerous pathogens and safeguard surfaces and costly equipment from damage. We work closely with experts in the field and our customers on the ground to ensure product development is inspired and informed by their evolving needs.

Clorox Healthcare is committed to providing the efficacy, compatibility and aesthetics healthcare facilities need. Begin-ning with the launch of Clorox Healthcare® Fuzion™ Cleaner Disinfectant, a new type of bleach that combines disinfecting efficacy against tough-to-kill pathogens like C. difficile with the aesthetics required for broad use throughout the facility, we are leading a push to eliminate the need to make tradeoffs between efficacy and surface compatibility that will include enhancing trusted formulations to provide the same great

“While focused on reducing HAI rates, healthcare facilities also face

significant pressure to minimize compatibility issues. ”

— Danielle Augustin-Glenn, PhD, Research Scientist, Clorox Healthcare

Building on a century-long legacy in cleaning and disinfecting, Clorox Healthcare offers a wide range of solutions to help stop the spread of infection in healthcare facilities. From comprehensive surface disinfection, including advanced ultraviolet technology, to skin antisepsis, we are committed to providing efficacious solutions, designed for compliance, to safeguard patient environments. For more information, visit www.CloroxHealthcare.ca or follow @CloroxHealth on Twitter.

RethinkBleach.com

• More places, more protection. C. difficile is not isolated to isolation rooms. Now you can confidently use bleach to broaden the reach of your patient environment protection. The efficacy you want, the aesthetics you need — bleach, reinvented.

• Easy on surfaces. Offers broad surface compatibility — including clear plastic, stainless steel, vinyl and more.

• Low residue. Leaves surfaces looking clean.

• Low odour. Light odour dissipates quickly.

• Kills C. difficile in 1 minute.

Use as directed. NI-37536

protectionthroughprevention™

FUZION™ IS HERE

Now there’s a bleach that’s easy on surfaces, so you can

use it more places and protect patient environments better.

Just think.

ZION™

5”

7.5”

NI-37536_PPD_HC_FuzionAd_HlfPg_Becker PROCESS SPOT COLORS SPECIAL

PROJECT TITLE BRAND PUB PROJECT MGR. / EXT.Fuzion 1/2 pg Ad PPD Beckers Michelle Ogata x7511

ARTWORK STAGE PRINT INFO SUBSTRATE DIMENSIONS APPLICATION/VERSIONMECH Offset / (4/0) Paper 7.5" W x 5" H InDesign CS2015

RELEASE DATE / VENDOR 04/07/17 / i4Color NOTES Dielines do not print. No Bleed Use Keyline

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 R1V204/06/17 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00 00/00/00

CL - - - - - - - - - - - - - - DESIGN REFERENCE

RG - - - - - - - - - - - - - - CC00

PMSXXXXCPMSXXXXY

PMSXXXXMPMSXXXXK

PMSXXXX VPMSXXXX D

CLOROXcreativeARTWORK & IMAGES Rights: Have Limited

USAGERIGHTS (File Name or Description) and Source

NI-37536_PPD_Fuzion_Artwork.ai

NI-34036_HospitalHallway_DoctorWithPatientEVSWorker_009_0516_i1.psd

12518_NI-33839_PPD_HC_FuzionBottle_0316_VS_R2_sm.psd

File Name or Description here and Source hereFile Name or Description here and Source hereFile Name or Description here and Source hereFile Name or Description here and Source here

ARTWORK RETRIEVAL APPROVALP&T REVIEW Andrew Gurnack DATE 7/25/16

14706

161396

1Clorox NI-37536_PPD_HC_FuzionAd _HlfPg_Becker_i01 4/10/2017 bl

61221 BROADWAY #287OAKLAND CA 94612

510-271-6569

efficacy but with lower residue and better compatibility. Our goal is to take the environment out of the equation for HAIs, and we will continue to improve our disinfectant offerings to safeguard patient environments.

###

Danielle Augustin-Glenn, PhD is a research scientist for Clorox Health-care where she supports the development and implementation of surface disinfection solutions in healthcare settings in the U.S. and Canada. Dr. Augustin-Glenn holds a doctoral degree in Microbial Pathogenesis from the University of California, Berkeley and a Master of Science degree in Medical Microbiology from San Francisco State University.

1. Kramer A, Schwebke I, Kampf G. How long do nosocomial patho-gens persist on inanimate surfaces? A systematic review. BMC Infec-tious Diseases. 2006;6:130. doi:10.1186/1471-2334-6-130.

2. Office of Disease Prevention and Health Promotion. "National Ac-tion Plan to Prevent Health Care-Associated Infections: Road Map to Elimination." Accessed March. 22, 2017.

3. "Preventing Device Related Healthcare Associated Infections." AAMI. Issues and Outcomes from the September 2016 Forum, Medi-cal Technology and HAI’s. Accessed March 01, 2017.

4. Calfee, DP, et al. "Understanding Barriers to Optimal Cleaning and Disinfection in Hospitals: A Knowledge, Attitudes, and Practices Sur-vey of Environmental Services Workers." Infect Control Hosp Epidemi-ol. 2016 37.12:1492-1495.

5. "Top 10 Health Technology Hazards for 2017." ECRI Institute. Ac-cessed Mar. 1, 2017.

6. Centers for Disease Control and Prevention (CDC) February 25th 2015 Press Release: "Nearly half a million Americans suffered from Clostridium difficile infections in a single year." Accessed Feb. 21, 2016.

Executive Briefing